Marie Danielle Vil

Statistics

Publications

Citations

370

H-Index

Active since

2003

Affiliations

SciClone Pharmaceuticals (United States)(Current)

Marie Danielle Vil is an author at SciClone Pharmaceuticals (United States) specializing in antibody engineering, therapeutic antibody development, and oncology.

Publications per year

2003–2009

Publications

Tailoring in Vitro Selection for a Picomolar Affinity Human Antibody Directed against Vascular Endothelial Growth Factor Receptor 2 for Enhanced Neutralizing Activity

Dan Lü, Juqun Shen, Marie Danielle Vil et al. · Journal of Biological Chemistry · 2003 · 184 citations · Full text

Medicine, Molecular Biology, Oncology +17

Development of a Fully Human Anti-PDGFRβ Antibody That Suppresses Growth of Human Tumor Xenografts and Enhances Antitumor Activity of an Anti-VEGFR2 Antibody

Juqun Shen, Marie Danielle Vil, Marie Prewett et al. · Neoplasia · 2009 · 63 citations · Full text

Medicine, Oncology, Pharmacology +16

Single Variable Domain-IgG Fusion

Juqun Shen, Marie Danielle Vil, Xenia Jimenez et al. · Journal of Biological Chemistry · 2006 · 50 citations · Full text

Pharmacy, Biotechnology, Molecular Biology +17

An antibody directed against PDGF receptor β enhances the antitumor and the anti-angiogenic activities of an anti-VEGF receptor 2 antibody

Juqun Shen, Marie Danielle Vil, Haifan Zhang et al. · Biochemical and Biophysical Research Communications · 2007 · 38 citations

Medicine, Cancer Biology, Oncology +16

Single variable domain antibody as a versatile building block for the construction of IgG-like bispecific antibodies

Juqun Shen, Marie Danielle Vil, Xenia Jimenez et al. · Journal of Immunological Methods · 2006 · 35 citations

Pharmacy, Biotechnology, Immunology +16

1–5 of 5